Results 31 to 40 of about 30,700 (263)
The study of the fetoplacental complex and the morphological research of placenta of 50 pregnant women with hyperandrogenism were conducted by the ultrasonic method, dopplerometry and cardiotocography.
S. V. Logvinov+4 more
doaj +1 more source
Androsterone glucuronide to dehydroepiandrosterone sulphate ratio is discriminatory for obese Caucasian women with polycystic ovary syndrome [PDF]
BACKGROUND: Androsterone glucuronide (ADTG) concentrations have been suggested as a marker of the effects of androgens at the target tissue level. As the mechanism for hyperandrogenemia in obese and nonobese polycystic ovary syndrome (PCOS) may differ ...
Ahmed, Lina+7 more
core +1 more source
PCOS without hyperandrogenism is associated with higher plasma Trimethylamine N-oxide levels
BackgroundPolycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder, and its pathogenesis is still under debate. Trimethylamine-N-oxide (TMAO) is a small, organic compound generated by the gut microbiome with a hypothesized relation to ...
Jiayu Huang+3 more
semanticscholar +1 more source
Background: Polycystic Ovarian Syndrome (PCOS) is the most common endocrinopathy in women of reproductive age, affecting 5-20% of women worldwide. Hyperandrogenism, as the primary characteristic of PCOS, is not always present in every patient.
Andon Hestiantoro+5 more
doaj +1 more source
Central Obesity and BMI Associated with Different Phenotypes of Polycystic Ovary Syndrome in Adolescent [PDF]
Adipose tissue distribution is effective in metabolic complications resulting from obesity. Fat accumulation in the body, particularly increase in visceral fat, is a major risk factor of diabetes and cardiovascular diseases.
Akbaezadeh, M. (Marzieh)+1 more
core +3 more sources
White blood cell counts (WBC), lymphocyte-to-monocyte ratio (LMR), and monocyte-to-high-density lipoprotein cholesterol ratio (MHR) are used as chronic inflammation markers.
M. Kałużna+8 more
semanticscholar +1 more source
HYPERANDROGENISM OF PUBERTY AGE AS A FACTOR REDUCING FERTILITY
Aim. Hyperandrogenism is a common cause of infertility in women. The onset of symptoms of hyperandrogenism takes place during puberty in the majority of women.
E. M. Bogatyreva+2 more
doaj +1 more source
Variations of Steroid Hormone Metabolites in Serum and Urine in Polycystic Ovary Syndrome after Nafarelin Stimulation: Evidence for an Altered Corticoid Excretion. [PDF]
To evaluate the clinical relevance of testing pituitary-ovarian responses in patients suffering from polycystic ovary syndrome (PCOS) with the GnRH agonist nafarelin, a 1.2-mg dose of nafarelin was given intranasally to 19 women with PCOS and 15 healthy ...
A. Lob+9 more
core +1 more source
Suppression of p66Shc prevents hyperandrogenism-induced ovarian oxidative stress and fibrosis
Rats with hyperandrogen-induced polycystic ovary syndrome (PCOS) have been shown to develop ovarian oxidative stress (OS) and fibrosis. The Sirt1 agonist, resveratrol, can reduce OS through inhibiting p66Shc in other models of OS.
Daojuan Wang+10 more
semanticscholar +1 more source
IntroductionPolycystic ovarian syndrome (PCOS) is the most frequent etiology of anovulation, hyperandrogenism and infertility in women. Its pathophysiology remains poorly elucidated.
Claire Rodier+11 more
doaj +1 more source